111, Inc. Announces Change to Board of Directors
111, Inc. (NASDAQ: YI) announced changes to its Board of Directors on November 4, 2024. Dr. Leon Lian Yong Chen has resigned from his director position for personal reasons, effective immediately. The company has appointed Mr. Yang "Luke" Chen, currently serving as Senior Finance Executive, as the new director. Dr. Chen had served on the board since May 2019. The company's Executive Chairman, Mr. Gang Yu, expressed gratitude for Dr. Chen's contributions and welcomed Luke Chen, highlighting his financial expertise and understanding of the business as valuable assets for the company's strategic initiatives.
111, Inc. (NASDAQ: YI) ha annunciato cambiamenti nel suo Consiglio di Amministrazione il 4 novembre 2024. Il Dr. Leon Lian Yong Chen si è dimesso dalla sua posizione di direttore per motivi personali, con effetto immediato. L'azienda ha nominato Mr. Yang "Luke" Chen, attualmente in veste di Senior Finance Executive, come nuovo direttore. Il Dr. Chen era membro del consiglio dal maggio 2019. Il Presidente Esecutivo dell'azienda, Mr. Gang Yu, ha espresso gratitudine per il contributo del Dr. Chen e ha dato il benvenuto a Luke Chen, sottolineando la sua esperienza finanziaria e comprensione del business come risorse preziose per le iniziative strategiche dell'azienda.
111, Inc. (NASDAQ: YI) anunció cambios en su Junta Directiva el 4 de noviembre de 2024. El Dr. Leon Lian Yong Chen ha renunciado a su puesto de director por razones personales, con efecto inmediato. La compañía ha designado a Mr. Yang "Luke" Chen, quien actualmente se desempeña como Ejecutivo Financiero Senior, como el nuevo director. El Dr. Chen había estado en la junta desde mayo de 2019. El Presidente Ejecutivo de la compañía, Mr. Gang Yu, expresó su agradecimiento por las contribuciones del Dr. Chen y dio la bienvenida a Luke Chen, destacando su experiencia financiera y comprensión del negocio como activos valiosos para las iniciativas estratégicas de la empresa.
111 Inc. (NASDAQ: YI)은 2024년 11월 4일 이사회 변경을 발표했습니다. 레온 리안 용 첸 박사는 개인적인 이유로 즉시 이사직에서 사임했습니다. 회사는 현재 수석 재무 임원으로 재직 중인 양 "루크" 첸을 새로운 이사로 임명했습니다. 첸 박사는 2019년 5월부터 이사회에서 활동해왔습니다. 회사의 이사회 의장인 강 유 씨는 첸 박사의 기여에 감사의 뜻을 전하며, 루크 첸을 환영하며 그의 재무 전문성과 기업에 대한 이해가 회사의 전략적 이니셔티브에 가치 있는 자산이라고 강조했습니다.
111, Inc. (NASDAQ: YI) a annoncé des changements dans son Conseil d'Administration le 4 novembre 2024. Le Dr Leon Lian Yong Chen a démissionné de son poste de directeur pour des raisons personnelles, avec effet immédiat. L'entreprise a nommé M. Yang "Luke" Chen, actuellement Senior Finance Executive, comme nouveau directeur. Le Dr Chen faisait partie du conseil depuis mai 2019. Le Président Exécutif de l'entreprise, M. Gang Yu, a exprimé sa gratitude pour les contributions du Dr Chen et a souhaité la bienvenue à Luke Chen, soulignant que son expertise financière et sa compréhension du secteur sont des atouts précieux pour les initiatives stratégiques de l'entreprise.
111, Inc. (NASDAQ: YI) gab am 4. November 2024 Änderungen im Vorstand bekannt. Dr. Leon Lian Yong Chen hat aus persönlichen Gründen mit sofortiger Wirkung von seiner Direktorposition zurückgetreten. Das Unternehmen hat Mr. Yang "Luke" Chen, der derzeit als Senior Finance Executive fungiert, zum neuen Direktor ernannt. Dr. Chen war seit Mai 2019 im Vorstand tätig. Der Vorstandsvorsitzende des Unternehmens, Mr. Gang Yu, drückte seine Dankbarkeit für die Beiträge von Dr. Chen aus und begrüßte Luke Chen, während er dessen finanzielle Expertise und Verständnis des Geschäfts als wertvolle Vermögenswerte für die strategischen Initiativen des Unternehmens hervorhob.
- Appointment of Senior Finance Executive to board indicates strong internal succession planning
- New director brings financial expertise and business understanding to the board
- Departure of experienced board member who served since 2019
Dr. Lian Yong Chen has served on the board of directors of the Company since May 2019. "I am grateful to Dr. Chen for his significant contributions during his term of office. His knowledge and advice have been invaluable in propelling our goals and strategies for long-term achievements. On behalf of the board, I extend best wishes to Dr. Chen and look forward to further collaborating with him in the future," said Mr. Gang Yu, Co-Founder and Executive Chairman of the Company.
Regarding the appointment of Mr. Yang "Luke" Chen, Mr. Gang Yu added, "We are delighted to welcome Luke to our board of directors. His extensive financial expertise and deep understanding of our business will be instrumental as we continue to drive our strategic initiatives forward. I am confident that his leadership and insights will contribute to our ongoing success and growth."
Forward-Looking Statements
This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in
For more information on 111, please visit: http://ir.111.com.cn/.
View original content:https://www.prnewswire.com/news-releases/111-inc-announces-change-to-board-of-directors-302294966.html
SOURCE 111, Inc.
FAQ
Who replaced Dr. Leon Lian Yong Chen on 111, Inc.'s (YI) board of directors?
When did Dr. Leon Lian Yong Chen resign from 111, Inc.'s (YI) board?